Relmada Therapeutics RLMD SEC Filings

NASDAQ RLMD
$4.38 +0.01 (+0.11%)
As of: Sep 4, 2026 · 11:51 AM EDT
EDGAR Disclosures

Regulatory Filings

Source SEC EDGAR

Every regulatory document Relmada Therapeutics, Inc. (RLMD) has filed with the SEC, as reported on EDGAR — annual and quarterly reports, current reports, insider transactions and ownership disclosures. Filter by form group, form type or period, and open any filing or its index directly.

# Form Type Form Group Accession Date Filing Index